The Venom-based derivatives DEX Gravix has been featured in a story on the popular online tech blog @hackernoon
Grand View Research stated that the global leveraged trading market was valued at approximately $4.4 trillion in 2020 and is expected to reach $6.8 trillion by 2028, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period.
This rise could be credited to online trading platforms. These platforms offer leveraged products such as contracts for difference (CFDs), futures, and margin trading, which enables traders to speculate on various financial instruments with leverage.
Gravix is a decentralized trading platform that allows users to trade cryptocurrencies, stocks and forex with leverage via long and short positions on both Venom and Everscale blockchains. At the core of the Gravix protocol are liquidity providers who act as market makers for all users. They allow traders to open positions on any asset at the current market price with a low spread. This means that traders can quickly and easily buy or sell any asset on the platform. It also connects to both Everscale and Venom (which is the first blockchain to be licensed by the Abu Dhabi Global Market (ADGM).
Leveraged trading has attracted both experienced traders looking to maximize their potential returns and novice traders seeking to enter the financial markets with limited capital. The appeal lies in the potential for significant gains within short periods.
Grand View Research stated that the global leveraged trading market was valued at approximately $4.4 trillion in 2020 and is expected to reach $6.8 trillion by 2028, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period.
This rise could be credited to online trading platforms. These platforms offer leveraged products such as contracts for difference (CFDs), futures, and margin trading, which enables traders to speculate on various financial instruments with leverage.